Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1904 | 2364 | 42.8 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1729 | 6061 | PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PACAP | Author keyword | 676 | 71% | 23% | 552 |
2 | PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE | Author keyword | 254 | 72% | 8% | 197 |
3 | PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE PACAP | Author keyword | 110 | 81% | 3% | 67 |
4 | US J AN BIOMED S | Address | 108 | 78% | 3% | 71 |
5 | HEBERT | Address | 79 | 76% | 2% | 56 |
6 | VIP | Author keyword | 78 | 27% | 10% | 244 |
7 | PAC1 RECEPTOR | Author keyword | 57 | 79% | 2% | 37 |
8 | PACAP RECEPTOR | Author keyword | 41 | 85% | 1% | 22 |
9 | PAC1 | Author keyword | 40 | 58% | 2% | 45 |
10 | PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE | Author keyword | 38 | 62% | 2% | 39 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PACAP | 606 | 76% | 18% | 429 |
2 | CYCLASE ACTIVATING POLYPEPTIDE | 510 | 46% | 35% | 830 |
3 | PEPTIDE PACAP | 155 | 95% | 2% | 53 |
4 | PACAP RECEPTOR | 143 | 81% | 4% | 86 |
5 | POLYPEPTIDE PACAP | 138 | 77% | 4% | 94 |
6 | HYPOTHALAMIC PEPTIDE | 135 | 67% | 5% | 121 |
7 | VASOACTIVE INTESTINAL PEPTIDE | 122 | 17% | 29% | 674 |
8 | HYPOTHALAMIC POLYPEPTIDE | 116 | 88% | 2% | 56 |
9 | 38 AMINO ACID FORM | 77 | 96% | 1% | 24 |
10 | VIP | 63 | 22% | 11% | 260 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions | 2000 | 789 | 844 | 69% |
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery | 2009 | 286 | 1330 | 71% |
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide | 1998 | 517 | 78 | 79% |
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1 | 2012 | 55 | 173 | 69% |
Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems | 1998 | 353 | 199 | 80% |
The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily | 2000 | 450 | 591 | 49% |
VPAC and PAC receptors: From ligands to function | 2009 | 137 | 313 | 53% |
Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Modulating Hypothalamus-Pituitary Neuroendocrine Functions in Mouse Cell Models | 2015 | 1 | 79 | 49% |
Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo | 2011 | 42 | 175 | 82% |
Pituitary adenylate cyclase activating polypeptide: A potential neuroprotective peptide | 2004 | 144 | 296 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | US J AN BIOMED S | 108 | 78% | 3.0% | 71 |
2 | HEBERT | 79 | 76% | 2.4% | 56 |
3 | PTE MTA LENDULET PAC TEAM | 34 | 79% | 0.9% | 22 |
4 | NEUROHUMORAL REGULAT GRP | 14 | 48% | 0.9% | 21 |
5 | SECT DEV MOL PHARMACOL | 12 | 40% | 1.0% | 24 |
6 | EXPT ZOOL NEUROBIOL | 12 | 36% | 1.1% | 27 |
7 | SPORTBIOL | 12 | 63% | 0.5% | 12 |
8 | MOL NEUROPHARMACOL | 9 | 12% | 3.2% | 75 |
9 | PTE MTA LENDULET PAC GRP | 9 | 83% | 0.2% | 5 |
10 | CHIM BIOL NUTR | 7 | 41% | 0.5% | 13 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232770 | PARASITOL BIOMED//VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1//RAT PERITONEAL MACROPHAGES |
2 | 0.0000185473 | HELODERMIN//HELOSPECTIN//PREPRO VIP MESSENGER RNA |
3 | 0.0000163041 | ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN |
4 | 0.0000136137 | SECRETIN RECEPTOR//SECRETIN//SECRETIN RECEPTORS |
5 | 0.0000077702 | ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST |
6 | 0.0000040345 | LUMBAR SPLANCHNIC NERVE//RAT SEMINAL VESICLE//MALE UROGENITAL APPARATUS |
7 | 0.0000040159 | PNEUMADIN//ADRENAL INNERVATION//LIPID CYTOPLASM RATIO |
8 | 0.0000036947 | INHIBITORY JUNCTION POTENTIAL//NITRERGIC NEUROTRANSMISSION//RAT GASTRIC FUNDUS |
9 | 0.0000029037 | GPR12//GPR6//HOMOLOGY PROBING |
10 | 0.0000026148 | CLASSICAL TRANSMITTER//CLASSICAL NEUROTRANSMITTER//CLASSICAL TRANSMITTERS |